Why consider treatment in China for Multiple Sclerosis?

China offers advanced stem cell therapies for MS at leading neurology centers, often at a fraction of the cost in Western countries. Many Chinese hospitals have extensive experience with autologous hematopoietic stem cell transplant (AHSCT) and umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy, using protocols that meet international standards. Additionally, patients benefit from shorter waiting times and access to integrated care teams that include neurologists, immunologists, and rehabilitation specialists. The combination of competitive pricing, skilled physicians, and modern facilities makes China a viable option for international patients.